Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARA vs HDAC as Consolidation in Younger Patients With Newly-Diagnosed AML
NCT00932412Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2009
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of clofarabine in acute myeloid leukemia (AML) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Disease Free Survival at 2 years. Started Mar 2009; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00932412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00932412.